Table 2 Logistic regression analysis for predicting relapse of GPA

Initial presentation: nose

Did not have

1

0.10–0.49

 < 0.001

Did have

0.22

Initial presentation: sinus

Did not have

1

0.28–1.10

0.93

Did have

0.56

Initial presentation: lung

Did not have

1

0.48–12.64

0.27

Did have

2.52

PR3-ANCA

Negative

1

1.29–5.31

0.007

Positive

2.62

MPO-ANCA

Negative

1

0.25–1.92

0.48

Positive

0.70

Eosinophilia

Negative

1

0.19–6.34

0.92

Positive

1.10

BVAS at diagnosis

 < 8.5

1

0.65–3.34

0.34

 ≥ 8.5

1.49

During follow-up: nose

Did not have

1

1.43–6.26

0.004

Did have

3.00

During follow-up: eye

Did not have

1

0.81–3.15

0.17

Did have

1.60

During follow-up: mucosal membranes

Did not have

1

1.43–12.38

0.009

Did have

4.21

During follow-up: skin

Did not have

1

0.89–6.88

0.83

Did have

2.47

During follow-up: heart

Did not have

1

0.50–39.86

0.18

Did have

4.46

During follow-up: GI

Did not have

1

1.14–27.90

0.03

Did have

5.64

During follow-up: arthritis

Did not have

1

0.67–11.64

0.16

Did have

2.80